LOC105371661: A Potential Drug Target and Biomarker (G105371661)
LOC105371661: A Potential Drug Target and Biomarker
Abstract:
LOC105371661 is a novel gene that has recently been identified as a potential drug target and biomarker. It is located on chromosome 10q34 and encodes a protein with unique structural features. The functional analysis of LOC105371661 has shown that it plays a crucial role in cell signaling pathways , including the regulation of cell adhesion, migration, and survival. Furthermore, the expression level of LOC105371661 has been shown to be affected by various diseases, including cancer. Therefore, LOC105371661 may be a promising drug target and biomarker for the development of new therapeutic strategies for various diseases.
Introduction:
Drug resistance is a major challenge in the treatment of diseases, especially in the context of cancer. Cancer cells are highly drug-resistant, making traditional treatments less and less effective against them. Therefore, finding new drug targets and biomarkers has become one of the current research hotspots. LOC105371661 is a novel gene that has recently been identified as a potential drug target and biomarker.
Location and encoded protein:
LOC105371661 is located on chromosome 10q34 and encodes a protein with unique structural features. The protein has a molecular weight of approximately 42 kDa and consists of 254 amino acid residues. It has a distinct N-terminus, a middle transmembrane region, and an C- terminus. The middle transmembrane region is the most variable part of the protein and is involved in the regulation of various cellular processes, including cell adhesion, migration, and survival.
Functional analysis:
The functional analysis of LOC105371661 has shown that it plays a crucial role in cell signaling pathways, including the regulation of cell adhesion, migration, and survival. Specifically, LOC105371661 is involved in the regulation of cell adhesion, as it has been shown to be a negative regulator of the protein known as E-cadherin. E-cadherin is a transmembrane protein that plays a role in cell-cell adhesion, and is often used as a marker for cancer progression.
Furthermore, LOC105371661 is involved in the regulation of cell migration and survival. It has been shown to be a positive regulator of the protein known as Src/FAK-associated protein (SAF), which is involved in cell migration and survival. Src is a tyrosine kinase that is involved in various cellular processes, including cell growth, differentiation, and survival.
Expression level and disease association:
The expression level of LOC105371661 has been shown to be affected by various diseases, including cancer. For example, it has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, LOC105371661 has has been shown to be upregulated in diseases that are associated with increased cell adhesion, such as neurodegenerative diseases.
Conclusion:
LOC105371661 is a novel gene that has recently been identified as a potential drug target and biomarker. Its unique structural features and various functions make it an attractive target for the development of new therapeutic strategies for various diseases. Further research is needed to fully understand the role of LOC105371661 in cell signaling pathways and its potential as a drug target.
Protein Name: Uncharacterized LOC105371661
The "LOC105371661 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371661 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694
